1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
2021)(
- Book/Report › Report
- 2014
-
Mark
The ”opt out” and “opt in” provisions in the Unified Patent Court Agreement – Impact and strategies for European patent portfolios
(
- Contribution to journal › Article
- 2012
-
Mark
The US Supreme Court in Mayo v Prometheus - taking the fire from or to biotechnology and personalized medicine?
(
- Contribution to journal › Article
-
Mark
What intent, whose intent and to what extent?: The Knowledge requirement in indirect patent infringement
(
- Contribution to journal › Article
-
Mark
The industrial application requirement for biotech inventions in light of recent EPO & UK case law:: A plausible "hunting license"?"
(
- Contribution to journal › Article
- 2011
-
Mark
US Patent Eligibility in the Wake of Bilski v Kappos: "Business as Usual" in an Age of New Technologies?
(
- Contribution to journal › Article
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO--Part I
(
- Contribution to journal › Article
-
Mark
Contribution to case law summaries and comments: Tri-lingual
2011)(
- Book/Report › Book
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO – Part I
(
- Contribution to journal › Article
- 2009
-
Mark
“Restoring the balance: The patentability of DNA-related technology in the US and Europe”
2009) Scholarship speech prepared for the AWAPATENT Foundation for the Promotion of Scientific Research in the Area of Intellectual Property Rights. p.1-10(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding